Absence of secondary sex characteristics
|
phenotype |
|
Finding
|
44
|
|
0.100 |
None |
|
0 |
|
|
|
Enlarged polycystic ovaries
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.400 |
None |
0.944 |
304 |
9
|
1980 |
2020 |
Carcinoid tumor, malignant
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1
|
2
|
0.010 |
None |
1.000 |
1 |
|
1980 |
1980 |
Atypical carcinoid tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
2
|
0.010 |
None |
1.000 |
1 |
|
1980 |
1980 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.700 |
None |
0.968 |
2998 |
43
|
1981 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.943 |
1380 |
16
|
1981 |
2020 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.400 |
None |
0.957 |
70 |
4
|
1982 |
2019 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.320 |
None |
1.000 |
16 |
|
1982 |
2016 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
1.000 |
None |
0.967 |
3371 |
41
|
1983 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.500 |
None |
0.978 |
551 |
8
|
1988 |
2020 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.100 |
None |
0.984 |
548 |
1
|
1988 |
2020 |
Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2283
|
178
|
0.100 |
None |
1.000 |
23 |
|
1988 |
2019 |
Osteosarcoma of bone
|
disease |
Neoplasms
|
Neoplastic Process
|
2247
|
151
|
0.100 |
None |
1.000 |
20 |
|
1988 |
2019 |
Childhood Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2208
|
151
|
0.100 |
None |
1.000 |
19 |
|
1988 |
2019 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.100 |
None |
0.906 |
32 |
|
1989 |
2019 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
634
|
43
|
0.100 |
None |
0.909 |
11 |
|
1989 |
2018 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.060 |
None |
1.000 |
6 |
|
1989 |
2018 |
Herpes Simplex Infections
|
group |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
645
|
11
|
0.030 |
None |
1.000 |
3 |
|
1989 |
2019 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.020 |
None |
1.000 |
2 |
|
1989 |
2015 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.972 |
108 |
1
|
1990 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
0.933 |
89 |
2
|
1990 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.600 |
None |
0.947 |
57 |
1
|
1990 |
2019 |
Node-negative breast cancer
|
disease |
|
Neoplastic Process
|
54
|
2
|
0.100 |
None |
1.000 |
11 |
|
1990 |
2019 |
Adult Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
405
|
30
|
0.050 |
None |
0.800 |
5 |
|
1990 |
2018 |